Furthermore, lenvatinib inhibits RET, which is important for controlling tumor growth and, by hitting FGFR and PDGFRβ, it also influences the tumor’s microenvironment, as presented in Figure 1 [22]. The gene discussed is RET; the disease is neoplasm.